Peter Tombros, 51 years old, was named president and chief executive officer of this biotechnology company.
Mr. Tombros succeeds Abraham Abuchowski, 45, who continues as chairman.
Mr. Tombros was previously vice president, corporate strategy planning, at pharmaceutical and health-care company Pfizer Inc.
